In a significant advancement in the field of medical imaging, a recent publication in the esteemed journal Magnetic Resonance in Medicine introduces comprehensive guidelines for quantitative cerebral perfusion MRI using multi-timepoint arterial spin labeling (ASL). The paper, titled "Recommendations for quantitative cerebral perfusion MRI using multi-timepoint arterial spin labeling: Acquisition, quantification, and clinical applications", serves as a crucial resource for both researchers and clinicians interested in cerebral perfusion imaging.
The article includes contributions from our CEO at Gold Standard Phantoms, Prof. Xavier Golay, an honorary professor of the University College of London's Institute on Neurology and a revered figure in MRI research. Prof. Golay's involvement underscores the integration of academic expertise and industry innovation, driving forward the capabilities and applications of MRI technology.
Central to enhancing the precision and reliability of MRI perfusion measurements is the innovative QASPER phantom from Gold Standard Phantoms. The QASPER phantom, or Quantitative Arterial Spin Labeling Perfusion Reference, is designed to simulate the delivery of arterial blood to an organ. This technology serves as a calibration and quality assurance standard, ensuring that MRI perfusion measurements are both controlled and reproducible. QASPER's design enables it to mimic the complex physiological process of blood flow to the brain, providing a consistent and standardized reference that can be used across different MRI machines and settings. This capability is crucial for advancing the clinical applications of MRI, particularly in diagnosing and monitoring diseases that affect cerebral blood flow, such as stroke and dementia.
The guidelines proposed in the publication, combined with the application of the QASPER phantom, pave the way for significant enhancements in the field of MRI. These developments promise to improve the accuracy of diagnosing neurological conditions and enable a more detailed understanding of cerebrovascular diseases. By standardizing ASL MRI procedures, researchers and clinicians can confidently compare studies and progress toward more personalized medicine approaches. The collaboration between academia and industry, exemplified by Prof. Golay’s co-authorship and the technological innovation of QASPER, highlights an exciting era of improved diagnostic tools and refined imaging techniques. With these advancements, the medical community steps closer to offering better, more precise patient care and fostering further research in cerebral perfusion.
Explore more about how our new QASPER is setting the gold standard in MRI perfusion measurements on our QASPER product page.
Read the full publication on Wiley Online Library website here: https://onlinelibrary.wiley.com/doi/epdf/10.1002/mrm.30091
GSP stands at the forefront of a ground-breaking evolution in medical imaging, embodying precision, reliability, and innovation. Founded on the principle that accurate diagnosis is the cornerstone of effective treatment, GSP introduced over the last 9 years an unparalleled suite of quality assurance and calibration devices, called phantoms, designed to revolutionise the field of MRI. These phantoms, meticulously engineered to simulate the physical properties of human tissue, offer a new benchmark in the validation and standardisation of imaging techniques across the whole MRI field.
GSP’s has recently developed the first-ever one-stop-shop calibration technology. Combining embedded phantoms with calibration software provided through a subscription as software as a medical device (SaaMD). Early results from this ground-breaking technology received a lot of interest from the major OEMs in this sector at the recent European Congress of Radiology held in Vienna at the beginning of March.
Why GSP?
Precision and Reliability:
Our phantoms ensure consistent and accurate imaging, essential for effective diagnosis and treatment.
Innovation:
The first-ever one-stop-shop calibration technology, combining embedded phantoms with calibration software, has already caught the attention of major OEMs.
Expertise:
Our co-founders, Prof. Xavier Golay, Dr. Aaron Oliver-Taylor, and Dr. Tom Hampshire, bring over 50 years of combined experience in MRI technology.
With over 125 million MRI scans performed annually worldwide, GSP is poised to capture a significant market share with our potentially revolutionary technology. Globally over 5000 MRI machines are bought yearly with an estimated 50,000 currently installed in OECD countries. With a global market worth $5.2B in 2023 and a CAGR of 5%, GSP is positioned to capture a sizable share with its potentially revolutionary technology.
GSP originated in London but has relocated to Sheffield, following an emerging trend of companies migrating to the secret startup capital of the UK.
For GSP, Sheffield was the obvious choice given its access to two major universities, facilities such as the Advanced Manufacturing Research Centre (AMRC), and several major teaching hospitals.
Co-founders Prof. Xavier Golay, Dr. Aaron Oliver-Taylor, and Dr. Tom Hampshire, initially crossed paths in their separate departments at University College London. Having worked together since 2014, the team combined comes with more than 50 years of experience in the field.
Xavier Golay, co-founder & CEO, started his PhD in MRI in 1994 and pursued a career that brought him from Switzerland to UCL as Professor of MR Physics, via Johns Hopkins in the USA and Philips Healthcare in Singapore. In June 2023, he decided that he could no longer sustain both academic and commercial activities and gave up his post at UCL to take over the helm of the company full-time.
Aaron Oliver Taylor, Co-Founder & CTO, finished his PhD in MRI in 2012 at UCL, where he met Xavier and first talked about developing calibration devices for MRI, which eventually led to the foundation of GSP. Aaron is an amazing multitasker, with a breadth of knowledge spanning chemistry, electronics, imaging, and hardware development. He has worked at the company as CTO since its inception.
Tom Hampshire, Co-Founder & CIO, is a computer scientist and software engineer, with a PhD in Medical Image Computing (2013). Tom has been the driving force behind the software development of the company. With such skills, he was a natural third founder to the team, helping shape the company into what it has become today.
Investor link: https://www.eventbrite.co.uk/e/ampere-x-stp-pitching-day-for-investors-tickets-849498150837
Founder link: https://ampere.events/event/ampere-events-x-stp-investor-event-pitching/
Electric Works: 3 Concourse Way, Sheffield City Centre, Sheffield S1 2BJ
Gold Standard Phantoms, a pioneer in the production of high-precision MRI phantoms, is thrilled to announce its strategic collaboration with NordicNeuroLab (https://www.nordicneurolab.com), a global leader in MR-conditional medical equipment for functional MRI studies.
This partnership marks a significant milestone in the fields of MRI research, clinical radiology, and neuroscience.
The partnership between Gold Standard Phantoms and Nordic NeuroLab is poised to greatly benefit researchers, clinicians, and technicians working in these critical domains. Specifically, this collaboration will facilitate the provision of fMRI phantoms by Gold Standard Phantoms to NordicNeuroLab's partners and clients. These Phantoms play a pivotal role in ensuring the quality assurance and performance assessment of MR scanners, a fundamental aspect of MRI research and clinical practice.
George Georgitsis, Director of Business Development for Gold Standard Phantoms, expressed enthusiasm about this collaboration, stating:
"This is a great opportunity for Gold Standard Phantoms to enter the clinical market, as NordicNeuroLab is an established leader in providing MRI equipment and services to hospitals worldwide. NordicNeuroLab defines the field of functional MR imaging, offering integrated hardware and software solutions for clinical fMRI, and we are excited that our phantoms are now part of their product and service catalog."
Thomas Omdahl, CEO at NordicNeuroLab, stated about the partnership:
"We are thrilled to join forces with Gold Standard Phantoms to provide our customers access to their top-tier MRI phantoms. This collaboration aligns perfectly with our commitment to promoting the adoption of fMRI in clinical practice, enabling us to offer more comprehensive and reliable products to our clients."
Gold Standard Phantoms is a dynamic spinout company from the renowned University College London's Institute of Neurology. Their mission is to revolutionize medical imaging by bridging the gap between pattern recognition and precise scientific measurement. Through strategic collaborations with clinicians, radiographers, radiological societies, imaging manufacturers, pharmaceutical companies, and regulatory bodies, they offer a comprehensive solution for maintaining standards in quantitative medical imaging. Learn more at www.goldstandardphantoms.com.
NordicNeuroLab is the leading global producer of MR-conditional medical equipment for functional MRI studies, used for pre-surgical assessment and research into various neurological conditions and processes. The company is dedicated to developing and commercializing solutions for functional imaging to improve patient care and clinical efficacy. Additionally, NordicNeuroLab is emerging as a global leader in MR patient comfort solutions and is entering the MR image-guided segment with displays and communication systems for use in the MR environment. Learn more at www.nordicneurolab.com.
The full PDF Press release is here
Gold Standard Phantoms is proud to have been recognised on the Tech Climbers Yorkshire list for 2023. This accolade further solidifies the company's position as a leader in the creation of phantoms and calibration objects for quantitative MRI, making significant strides in the technology field.
Gold Standard Phantoms, a UCL spin-out company, focuses on developing cutting-edge calibration objects that improve the reliability of MRI scans, ensuring the highest quality of medical diagnostics. For the past year Gold Standard Phantoms has been proud to call Sheffield home, and this award underlines its commitment to contributing to the area's thriving tech ecosystem.
"We are deeply honoured to have our efforts acknowledged and celebrated as we make the Tech Climbers Yorkshire list for 2023,"
says Professor Xavier Golay, CEO of Gold Standard Phantoms and former Professor at UCL Queen Square Institute of Neurology.
"This achievement underscores our passion and dedication to advancing technology in healthcare. We are also grateful to Business Sheffield for their invaluable support, which has undoubtedly contributed to our success. The strength of Sheffield's tech ecosystem lies in its diversity, innovation and collaboration, and we're proud to be part of this dynamic community,"
says George Georgitsis, Director of Business Development of Gold Standard Phantoms.
Business Sheffield has been an incredible support to Gold Standard Phantoms, providing resources and assistance that have greatly contributed to the company's achievements. Gold Standard Phantoms is proud to represent Sheffield on the Tech Climbers Yorkshire list, reaffirming its commitment to drive technological advancements in the medical imaging field.
For more information about Gold Standard Phantoms, visit www.GoldStandardPhantoms.com
About Gold Standard Phantoms:
Gold Standard Phantoms is a dynamic spin-out company from the renowned University College London's Institute of Neurology. Our mission is to revolutionise the field of medical imaging by bridging the gap between pattern recognition and precise scientific measurement. Through strategic collaborations with clinicians, radiographers, radiological societies, imaging manufacturers, pharmaceutical companies and regulatory bodies, we provide an all-encompassing solution for maintaining standards in quantitative medical imaging. Gold Standard Phantoms continues to strive towards technological advancement in healthcare.
Media Contact:
George Georgitsis
Director of Business Development
george.georgitsis@goldstandardphantoms.com
+44 7508 768083
